NCT05252585 2026-04-02
A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)
Novartis
Phase 4 Active not recruiting
Clinical Trials
14 trialsNCT06453642 2026-03-30
GPX
Fluidx Medical Technology, Inc.
Phase NA Active not recruiting
NCT06126159 2026-03-20
MRI Functional Imaging Characteristics and Fat Quantification of CT-fat-free Renal Neoplasms: Relationships With Histological Classifications and Molecular Markers
Chang Gung Memorial Hospital
Phase NA Active not recruiting
NCT06683846 2025-08-24
Ivonescimab in the Treatment of Multiple Advanced Tumors
Fudan University
Phase 2 Recruiting
NCT05785052 2023-03-27
BRC
Biorek S.R.L.
Recruiting
NCT02654340 2023-02-10
TuScCom
CENTOGENE GmbH Rostock
Terminated
NCT05617105 2022-11-15
PEComesCells
University Hospital, Strasbourg, France
Unknown
NCT02325505 2022-08-04
Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma
InCor Heart Institute
Completed
NCT00126672 2022-04-25
RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS
Dana-Farber Cancer Institute
Phase 2 Completed
NCT03525834 2021-09-09
Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.
Novartis
Phase 4 Completed
NCT03477149 2020-10-09
EASYX-1
Assistance Publique - Hôpitaux de Paris
Phase NA Completed
NCT00790400 2017-02-17
EXIST-2
Novartis
Phase 3 Completed
NCT01690871 2013-08-02
A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComa
Novartis
Phase 2 Withdrawn
NCT01217125 2012-03-08
Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis
Fundacio Puigvert
Phase 4 Completed